Le Lézard
Classified in: Health, Business
Subjects: SBS, CXP

Technipaq Investments Further Expand Packaging Capacity, Enhance Product Breadth and Customization

CRYSTAL LAKE, Ill., Jan. 14, 2019 /PRNewswire/ -- Technipaq Inc., one of the leading medical packaging manufacturers for the healthcare, medical device, diagnostic and life science industries, has further expanded and enhanced its production capacity with the addition of new printing and pouch fabricating machinery.

The company's most prominent new addition is a Platen Sealing Pouch System, which is designed for the high-efficiency production of chevron and other types of medical pouches. Featuring matchless process control and intelligent sealing technology, toolless die changes and other innovative features, this new equipment provides Technipaq with a significant competitive advantage regarding its breadth and variety of pouch products, overall production capacity and speed-to-market.  

In addition to the Platen machine, a new header bag will be installed in the 1st Quarter of 2019.  Of note are the hiring of additional engineers, industry specialists and on-floor inspectors. The company also re-certified its ISO 13845 designation. 

Further, Technipaq is now bolstering its Product Quality with the addition of Vision Detection System on pouch converting machines. Through its high-resolution camera detection and customized software, the system allows for continuous product flow inspection?performing multiple monitoring functions in parallel designed to detect flaws at a level far beyond what can be seen by the human eye.

"Making investments of this caliber are what keeps our company at the forefront of the industry, as they are completely in the best interest of our customer," said Technipaq President Brian Rosenburg. "It offers our customers an unmatched level of process control and further increases delivery speed to market. Perhaps most important, it helps ensure a defective product never reaches the hands of the end customer."

This is third major injection of capital back into the business in the past five years. It is part of a decade-long, multi-stage re-investment strategy designed to further expand its service offerings and production capacity to support the growth of its growing, global customer base.

"Since our inception 35 years ago, our focus has remained on delivering the highest quality packaging solutions and most robust array of design capabilities the industry has to offer," said Rosenburg. "From conception to creation to customization to the hands of the end customer, our goal is to make the investments today that meet our client's needs of tomorrow.

With more than 100,000 square-feet of manufacturing and warehousing space, Technipaq is capable of laminating, printing, slitting, sheeting, die-cutting, and fabricating flexible sterilize or non?sterilize bags and pouches to exact specifications.  The company is proudly one of only an elite few Authorized Converters of Medical Grade DuPonttm Tyvek® in North America,

For more than 35 years, Technipaq has been providing flexible, sterilized packaging solutions to the world's leading healthcare, medical device, diagnostic and life sciences companies. An ISO 13485 certified manufacturer with more than 100,000 square-feet of production and warehousing space, the company specializes in laminating, printing, slitting, sheeting, die-cutting, and fabricating flexible sterilizable bags and pouches customized to the most sophisticated design needs and delivered under the most demanding timeframes. Technipaq is proudly one of only an elite few Authorized Converters of Medical Grade DuPonttm Tyvek® in North America, specializing in converting Tyvek surgical papers, foils and films into high-barrier ETO, radiation and autoclave packaging. To learn more, please visit www.technipaq.com or download the corporate brochure here.

Media Contact:
Jay Virgil
(815) 477-1800

SOURCE Technipaq Inc.

These press releases may also interest you

at 20:07
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received EMA GMP certificates for...

at 20:01
The LATAM pharmaceutical excipients market is projected to grow at a CAGR of 7.5% during the forecast period (2019?2024).Read the full report: https://www.reportlinker.com/p05757917/?utm_source=PRN The Latin America pharmaceutical excipients market...

at 20:01
The global wearable medical devices market is expected to reach US$ 23,310.9 Mn in 2025 from US$ 6,231.7 Mn in 2017. The market is estimated to grow with a CAGR of 18.1% from 2018-2025.Read the full report:...

at 20:01
Medical Device Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Service (Chemistry, Biocompatibility, Microbiology & Sterility Testing), By Region, And Segment Forecasts, 2018 - 2025Read the full...

at 20:01
Paper Diagnostics Market Analysis Report By Device Type (Diagnostics, Monitoring), By Application, By Product (Lateral Flow Assays, Paper Based Microfluidics), By End Use, and Segment Forecasts, 2018 - 2025Read the full report:...

at 20:00
EXTRAKTLAB-shared recent honors from the cannabis industry as their DrainDroyd filtration unit was featured in Marijuana Business Magazine's "10 Killer Technologies" cover story. DrainDroyd ranked #3 in the feature article, which provides great...

News published on 14 january 2019 at 08:32 and distributed by: